| SCHINDLER DISEASE, TYPE I | |
| ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY, TYPE I; SCHINDLER DISEASE, TYPE III, INCLUDED | |
| 609241 OMIM = Online Mendelian Inheritance of Men | |
| 3137 | |
| Alpha-N-acetylgalactosaminidase | |
| 3.2.1.49 | |
| 22q13.2 | |
| E77.1 | |
| rare autosomal recessive mutation in the alpha-N-acetylgalactosaminidase gene (NAGA) type I: Schindler disease, infantile onset neuroaxonal dystrophy type II:Kanzaki disease, adult-onset peripheral neuroaxonal degeneration, angiokeratoma corporis diffusum and mild intellectual impairment may present as a non-disease (present healthy case) [Bakker HD et al. 2001] type III: intermediate form | |
| Laboratory findings | alpha-N-Acetylgalactosaminidase dec (fibroblasts) alpha-N-Acetylgalactosaminidase dec (lymphoblasts) alpha-N-Acetylgalactosaminidase dec (plasma) Glycopeptides inc (urine) Oligosaccharides inc (urine) | 
| Symptoms | blindness, visual loss, visual impairment cataract cerebellar atrophy or hypoplasia cerebral atrophy contractures, joints CT, brain, abnormalities [-] decreased muscle volume, atrophy or hypoplasia developmental delay EEG abnormalities [-] epilepsy hyperreflexia hypotonia mental retardation motor retardation MRI, brain, abnormalities [-] myoclonus neurological deterioration normal at birth nystagmus onset, childhood onset, infancy optic atrophy seizures strabismus |